Embolic Protection Device Market Global Forecast Report by Product (Distal Filter Devices, Distal Occlusion Devices, Proximal Occlusion Devices) Application (Coronary Artery Treatment, Carotid Artery Treatment, Others) Procedure (Percutaneous Coronary Intervention, Carotid Artery Stenosis, Saphenous Vein Graft Intervention, Aortic Valve Stenosis (Transcatheter Aortic Valve Replacement), Others) Material (Nitinol, Polyurethane) Usage (Disposable Devices, Re-Usable Devices) End-User (Hospitals and Clinics, Ambulatory Surgical Centers, Others) Countries and Company Analysis, 2024-2032

Growth Factors in the Embolic Protection Device Industry

An increase in cardiovascular disease prevalence

The market for embolic protection devices is primarily driven by the rise in cardiovascular disorders such as coronary artery disease and atherosclerosis. Interventions like angioplasty and stent implantation are becoming more common as the world's population ages and lifestyle choices contribute to health issues everywhere. The use of embolic protection devices is essential in reducing the risk of embolization, a potentially dangerous complication that can have serious repercussions such as stroke. These tools greatly enhance patient safety and treatment outcomes by collecting and controlling debris during these procedures. The increasing need for embolic protection devices is a result of medical practitioners' dedication to mitigating the procedural risks associated with the rising global burden of cardiovascular illnesses.

An increasing preference for minimally invasive procedures

The need for embolic protection devices is being driven by the growing use of minimally invasive procedures in a variety of medical specializations. These tools are critical to maintaining patient safety in operations such as transcatheter interventions, which have a high risk of embolization. The necessity for efficient embolic protection increases as less invasive procedures become more popular among patients and healthcare professionals because they promote speedier recovery times and shorter hospital stays. These devices' versatility in a range of minimally invasive (MI) treatments highlights their importance in contemporary medicine, where they are essential for achieving successful procedures and improving patient outcomes.

North America Embolic Protection Device Market Overview:

According to estimates, North America will hold the most market share for embolic protection devices globally. Due to the importance of major growth factors including the increase in cases of carotid artery disease and coronary heart disease, the rise in obesity rates, and other factors, the North American market for embolic protection devices is predicted to grow positively. Additionally, the region's highly developed healthcare system, high level of disposable income, growing regulatory approval for new technologies, and high level of awareness regarding minimally invasive surgery will all contribute to the market's growth.

The most prevalent form of heart disease in the US, coronary heart disease (CHD) caused 382,820 deaths in 2020, according to the Centers for Disease and Prevention Control (CDC) 2020 report. According to the same source (2022), there are around 805,000 heart attacks annually in the United States; of them, 605,000 are first-time victims, and 200,000 are those who have had heart attacks previously.

According to the CDC (2023), nearly two out of every five persons in the US have high blood cholesterol (total cholesterol = 200 mg/dL) annually, which increases the risk of heart disease and stroke. In order to remove thrombus, clogs, or plugs from the artery, an angioplasty may be necessary due to the rising number of heart attacks and strokes. During an angioplasty, a stent or balloon is utilized to unblock a blocked or restricted artery. An embolic protection device is also used to catch blood and luminal debris, preventing the debris from moving forward with the blood flow. As a result, rising heart attack and stroke rates in the US could necessitate more angioplasty procedures, which would ultimately raise demand for distal embolic protection devices in the area.

As a result, the previously mentioned elements would offer a favorable growth environment for the embolic protection device market in North America.

Embolic Protection Device Market Company Overview

Some of the industry leaders seen in the Global Embolic Protection Device Market Includes Abbott Laboratories, Allium Medical Solutions Ltd., Boston Scientific Corporation, Cardinal Health Inc., Edwards Lifesciences Corporation, Medtronic Inc., Silk Road Medical Inc.

Embolic Protection Device Market News

In September 2023, following regulatory approval, Penumbra and Asahi Intecc, a Japanese medical device manufacturer, announced that they would work together to bring Penumbra's Indigo aspiration system to the Japanese market. The Indigo aspiration system from Penumbra is a useful tool for treating pulmonary embolism and removing thrombi and emboli from venous and peripheral arterial systems.

In January 2023, Leading provider of medical services and solutions, Cardinal Health Inc., has partnered strategically with Palantir, a well-known IT firm that specializes in data integration and analysis. This creative collaboration is a major advancement in the field of supply chain management for healthcare. Together, the companies hope to realize a state-of-the-art clinically integrated supply chain solution that has the potential to completely transform the way healthcare organizations handle their distribution and inventory systems.

Product – Market breakup in 3 viewpoints:

1. Distal Filter Devices
2. Distal Occlusion Devices
3. Proximal Occlusion Devices

Application – Market breakup in 3 viewpoints:

1. Coronary Artery Treatment
2. Carotid Artery Treatment
3. Others

Procedure– Market breakup in 5 viewpoints:

1. Percutaneous Coronary Intervention
2. Carotid Artery Stenosis
3. Saphenous Vein Graft Intervention
4. Aortic Valve Stenosis (Transcatheter Aortic Valve Replacement)
5. Others

Material – Market breakup in 2 viewpoints:

1. Nitinol
2. Polyurethane

Usage – Market breakup in 2 viewpoints:

1. Disposable Devices
2. Re-Usable Devices

End User – Market breakup in 3 viewpoints:

1. Hospitals and Clinics
2. Ambulatory Surgical Centers
3. Others

Country – Market breakup in 25 viewpoints:

North America

• United States
• Canada

Europe

• France
• Germany
• Italy
• Spain
• United Kingdom
• Belgium
• the Netherlands
• Turkey

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Thailand
• Malaysia
• Indonesia
• New Zealand

Latin America

• Brazil
• Mexico
• Argentina

Middle East & Africa

• South Africa
• Saudi Arabia
• United Arab Emirates

All the Key players have been covered from 4 Viewpoints:

• Overviews
• Recent Developments & Strategies
• Product Portfolio & Product Launch in Last 1 Year
• Revenue

 Company Analysis:

1. Abbott Laboratories
2. Allium Medical Solutions Ltd.
3. Boston Scientific Corporation
4. Cardinal Health Inc.
5. Edwards Lifesciences Corporation
6. Medtronic Inc.
7. Silk Road Medical Inc.

Report Details: